Cresco Labs Statistics

Total Valuation

Cresco Labs has a market cap or net worth of CAD 414.68 million. The enterprise value is 1.01 billion.

Market Cap	414.68M
Enterprise Value	1.01B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Cresco Labs has 351.43 million shares outstanding. The number of shares has increased by 6.69% in one year.

Current Share Class	n/a
Shares Outstanding	351.43M
Shares Change (YoY)	+6.69%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	2.11%
Owned by Institutions (%)	15.96%
Float	327.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.40
PB Ratio	0.74
P/TBV Ratio	n/a
P/FCF Ratio	2.55
P/OCF Ratio	2.18
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.51, with an EV/FCF ratio of 6.23.

EV / Earnings	-9.45
EV / Sales	0.98
EV / EBITDA	3.51
EV / EBIT	6.28
EV / FCF	6.23

Financial Position

The company has a current ratio of 3.12, with a Debt / Equity ratio of 1.65.

Current Ratio	3.12
Quick Ratio	2.00
Debt / Equity	1.65
Debt / EBITDA	3.20
Debt / FCF	5.66
Interest Coverage	1.90

Financial Efficiency

Return on equity (ROE) is -14.82% and return on invested capital (ROIC) is 6.54%.

Return on Equity (ROE)	-14.82%
Return on Assets (ROA)	5.16%
Return on Invested Capital (ROIC)	6.54%
Return on Capital Employed (ROCE)	8.88%
Revenue Per Employee	355,125
Profits Per Employee	-36,933
Employee Count	2,900
Asset Turnover	0.53
Inventory Turnover	3.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.16% in the last 52 weeks. The beta is 2.04, so Cresco Labs's price volatility has been higher than the market average.

Beta (5Y)	2.04
52-Week Price Change	-58.16%
50-Day Moving Average	1.05
200-Day Moving Average	1.68
Relative Strength Index (RSI)	67.36
Average Volume (20 Days)	183,140

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cresco Labs had revenue of CAD 1.03 billion and -107.10 million in losses. Loss per share was -0.31.

Revenue	1.03B
Gross Profit	512.04M
Operating Income	161.08M
Pretax Income	-15.27M
Net Income	-107.10M
EBITDA	246.11M
EBIT	161.08M
Loss Per Share	-0.31

Full Income Statement

Balance Sheet

The company has 197.93 million in cash and 920.34 million in debt, giving a net cash position of -722.41 million or -2.06 per share.

Cash & Cash Equivalents	197.93M
Total Debt	920.34M
Net Cash	-722.41M
Net Cash Per Share	-2.06
Equity (Book Value)	558.52M
Book Value Per Share	1.96
Working Capital	287.65M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 190.62 million and capital expenditures -28.05 million, giving a free cash flow of 162.57 million.

Operating Cash Flow	190.62M
Capital Expenditures	-28.05M
Free Cash Flow	162.57M
FCF Per Share	0.46

Full Cash Flow Statement

Margins

Gross margin is 49.72%, with operating and profit margins of 15.64% and -10.40%.

Gross Margin	49.72%
Operating Margin	15.64%
Pretax Margin	-1.48%
Profit Margin	-10.40%
EBITDA Margin	23.90%
EBIT Margin	15.64%
FCF Margin	15.79%

Dividends & Yields

Cresco Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.69%
Shareholder Yield	-6.69%
Earnings Yield	-25.83%
FCF Yield	39.20%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cresco Labs has an Altman Z-Score of -0.05. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.05
Piotroski F-Score	n/a